Artiva Biotherapeutics (ARTV) Invested Capital: 2023-2025
Historic Invested Capital for Artiva Biotherapeutics (ARTV) over the last 3 years, with Sep 2025 value amounting to $129.2 million.
- Artiva Biotherapeutics' Invested Capital fell 35.71% to $129.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $129.2 million, marking a year-over-year decrease of 35.71%. This contributed to the annual value of $186.6 million for FY2024, which is 215.20% up from last year.
- According to the latest figures from Q3 2025, Artiva Biotherapeutics' Invested Capital is $129.2 million, which was down 13.30% from $149.0 million recorded in Q2 2025.
- Artiva Biotherapeutics' Invested Capital's 5-year high stood at $201.0 million during Q3 2024, with a 5-year trough of -$191.1 million in Q2 2024.
- In the last 3 years, Artiva Biotherapeutics' Invested Capital had a median value of -$11.1 million in 2023 and averaged -$880,900.
- As far as peak fluctuations go, Artiva Biotherapeutics' Invested Capital surged by 232.71% in 2024, and later slumped by 35.71% in 2025.
- Artiva Biotherapeutics' Invested Capital (Quarterly) stood at -$162.0 million in 2023, then spiked by 215.20% to $186.6 million in 2024, then tumbled by 35.71% to $129.2 million in 2025.
- Its Invested Capital was $129.2 million in Q3 2025, compared to $149.0 million in Q2 2025 and $168.8 million in Q1 2025.